{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:52:22Z","timestamp":1786719142358,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016085","name":"Advanced Innovation Center for Human Brain Protection, Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lanwpc.2020.100021","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T11:44:07Z","timestamp":1599392647000},"page":"100021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study"],"prefix":"10.1016","volume":"2","author":[{"given":"De-Cai","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-4637","authenticated-orcid":false,"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lanwpc.2020.100021_bib0001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.lanwpc.2020.100021_bib0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2020.100021_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.lanwpc.2020.100021_bib0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/WCO.0000000000000315","article-title":"Central nervous system neuroinflammatory disorders in Asian\/Pacific regions","volume":"29","author":"Kim","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.lanwpc.2020.100021_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp-2017-317321","article-title":"Nationwide epidemiological study of neuromyelitis optica in Japan","volume":"89","author":"Miyamoto","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0007","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","author":"Kim","year":"2019","journal-title":"Multipl Scleros"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Multip Scleros Relat Disord"},{"issue":"8","key":"10.1016\/j.lanwpc.2020.100021_bib0009","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.lanwpc.2020.100021_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.lanwpc.2020.100021_bib0011","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lanwpc.2020.100021_bib0012","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.lanwpc.2020.100021_bib0013","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1352458509102921","article-title":"Multiple sclerosis in China\u2013history and future","volume":"15","author":"Cheng","year":"2009","journal-title":"Multip Scleros"},{"issue":"10002","key":"10.1016\/j.lanwpc.2020.100021_bib0014","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(15)00343-8","article-title":"Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system","volume":"386","author":"Jiang","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanwpc.2020.100021_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12882-019-1538-0","article-title":"Association between the Charlson comorbidity index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis","volume":"20","author":"Lin","year":"2019","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.lanwpc.2020.100021_bib0016","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.lanwpc.2020.100021_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.lanwpc.2020.100021_bib0018","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000787","article-title":"Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders","volume":"7","author":"Fan","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.lanwpc.2020.100021_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(20)30070-3","article-title":"Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial","volume":"19","author":"Zhang","year":"2020","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.lanwpc.2020.100021_bib0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/jamaneurol.2017.1336","article-title":"Safety and efficacy of bortezomib in patients with highly relapsing neuromyelitis optica spectrum disorder","volume":"74","author":"Zhang","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0021","article-title":"Incidence of multiple sclerosis in China: a nationwide hospital-based study","author":"Tian","year":"2020","journal-title":"Lancet Reg Health \u2013 West Pac"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0022","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.msard.2018.07.003","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: a comparison in different ethnic groups","volume":"25","author":"Viswanathan","year":"2018","journal-title":"Multip Scleros Relat Disord"},{"issue":"11","key":"10.1016\/j.lanwpc.2020.100021_bib0023","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/1352458518792430","article-title":"A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia","volume":"25","author":"Viswanathan","year":"2019","journal-title":"Multip Scleros"},{"issue":"14","key":"10.1016\/j.lanwpc.2020.100021_bib0024","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sepulveda","year":"2018","journal-title":"Multip Scleros"},{"issue":"6","key":"10.1016\/j.lanwpc.2020.100021_bib0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/ane.12903","article-title":"Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region","volume":"137","author":"Dale","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.lanwpc.2020.100021_bib0026","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ene.14079","article-title":"A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary","volume":"27","author":"Papp","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0027","doi-asserted-by":"crossref","DOI":"10.1177\/2055217315625652","article-title":"Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: About one in a million","volume":"2","author":"Danielle van Pelt","year":"2016","journal-title":"Multip Scleros J \u2013 Exp Transl Clin"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 20082018: a nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Multipl Scleros Relat Disord"},{"issue":"11","key":"10.1016\/j.lanwpc.2020.100021_bib0029","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1179\/1743132815Y.0000000081","article-title":"Clinical manifestations of neuromyelitis optica in male and female patients","volume":"37","author":"Yin","year":"2015","journal-title":"Neurol Research"},{"issue":"6","key":"10.1016\/j.lanwpc.2020.100021_bib0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jnnp-2017-317566","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorders","volume":"89","author":"Mori","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.lanwpc.2020.100021_bib0031","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/jnnp-2016-314013","article-title":"Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis","volume":"87","author":"Tao","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0032","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica","volume":"384","author":"Ajmera","year":"2018","journal-title":"J Neurol Sci"},{"issue":"22","key":"10.1016\/j.lanwpc.2020.100021_bib0033","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: results from the china hypertension survey, 2012\u20132015","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lanwpc.2020.100021_bib0034","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","article-title":"Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"issue":"9680","key":"10.1016\/j.lanwpc.2020.100021_bib0035","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(09)60660-7","article-title":"Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001\u201305: an epidemiological survey","volume":"373","author":"Phillips","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2020.100021_bib0036","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Multip Scleros Relat Disord"},{"issue":"4","key":"10.1016\/j.lanwpc.2020.100021_bib0037","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"updated-by":[{"DOI":"10.1016\/j.lanwpc.2021.100118","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606520300213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606520300213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:34:05Z","timestamp":1763001245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606520300213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"alternative-id":["S2666606520300213"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2020.100021","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2020.100021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100021"}}